RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36278424http://www.w3.org/2000/01/rdf-schema#comment"Primary hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by impaired lymphocyte cytotoxicity. First-line therapeutic regimens directed against activated immune cells or secreted cytokines show limited efficacy since they do not target the underlying immunological problem: defective lymphocyte cytotoxicity causing prolonged immune stimulation. A potential rescue strategy would be the adoptive transfer of ex vivo gene-corrected autologous T cells. However, transfusion of cytotoxicity-competent T cells under conditions of hyperinflammation may cause more harm than benefit. As a proof-of-concept for adoptive T cell therapy (ATCT) under hyperinflammatory conditions, we transferred syngeneic, cytotoxicity-competent T cells into mice with virally triggered active primary HLH. ATCT with functional syngeneic trigger-specific T cells cured Jinx mice from active HLH without life-threatening side effects and protected Perforin-deficient mice from lethal HLH progression by reconstituting cytotoxicity. Cured mice were protected long-term from HLH relapses. A threshold frequency of transferred T cells with functional differentiation was identified as a predictive biomarker for long-term survival. This study is the first proof-of-concept for ATCT in active HLH."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.org/dc/terms/identifier"doi:10.15252/emmm.202216085"xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Cathomen T."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Ehl S."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Schell C."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Ammann S."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Aichele P."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Kogl T."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Weissert K."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/author"Dettmer-Monaco V."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/name"EMBO Mol Med"xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/pages"e16085"xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/title"Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)."xsd:string
http://purl.uniprot.org/citations/36278424http://purl.uniprot.org/core/volume"14"xsd:string
http://purl.uniprot.org/citations/36278424http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/36278424
http://purl.uniprot.org/citations/36278424http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/36278424
http://purl.uniprot.org/uniprot/#_A0A0R4J257-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_A2A855-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_A2A858-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_A2RSY7-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_B2RUP2-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_P10820-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424
http://purl.uniprot.org/uniprot/#_Q80UG7-mappedCitation-36278424http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36278424